Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin and Metformin in Women With Polycystic Ovary Syndrome
NCT05601336Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in polycystic ovary syndrome (PCOS), sponsored by Beni Suef University. Started May 2025; status: completed.
02
Drugs
dapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05601336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05601336.